![]() |
Professor Department of Medicine, Division of Endocrinology 830 Faculty Office Tower 510 20th Street South Birmingham, AL 35294-3408 Telephone:(205) 934-3235 Fax:(205) 934-4602 E-mail: slmorgan@uab.edu [1] |
Dr. Morgan is Professor of Nutrition Science and Medicine. She currently holds an appointment in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham as a Professor of Medicine
Dr. Morgan obtained two bachelor's degrees in nutrition and dietetics and nutrition and dietetics from Iowa State University. She obtained her medical degree from the University of Iowa in 1981 and completed an internship and residency in internal medicine at the University of Iowa in 1984. She completed a post doctoral fellowship in clinical nutrition at the University of Alabama at Birmingham and obtained a master's degree in clinical nutrition at the University of Alabama at Birmingham in 1987. She was a faculty member in the UAB Department of Nutrition Sciences and a professor Nutrition Sciences and Medicine until December 2010. In January 2011 she moved to the Division of Clinical Immunology and Rheumatology in the University of Alabama in Birmingham. She is the current medical director of the UAB Osteoporosis Prevention and Treatment Clinic and the UAB Bone Densitometry Service. The UAB Bone Densitometry Service was accredited by the International Society for Clinical Densitometry in 2011.
Dr. Morgan is a member of the American Dietetics Association, the American Society of Nutrition, The American Society of Bone and Mineral Research and the International Society for Clinical Densitometry. She served as the President for the International Society for Clinical Densitometry from 2011-2012 and current serves on the International Society for Clinical Densitometry Board and is a teacher in the Bone Density Course and the Vertebral Fracture Assessment course.
Dr. Morgan's research interests are around folic acid metabolism during methotrexate therapy for rheumatoid arthritis. Along with Dr. Joseph E Baggott, she described folic acid supplementation during low dose methotrexate therapy as a way to lower the toxicity of low dose methotrexate therapy. She has also been involved in investigations related to the mechanism of action of low-dose methotrexate (i.e. inhibition of AICAR transformylase). She is currently the CO-PI of a R34 grant to plan a larger trial related to the discontinuation of biological agents during methotrexate therapy for RA.
Dr. Morgan also has an interest in research related to dual-energy x-ray absorptiometry and participates in clinical trials related to osteoporosis in the Division of Clinical Immunology and Rheumatology.
Professor of Medicine,Division of Clinical Immunology and Rheumatology
Scientist- Center for Metabolic Bone Disease, Obesity Center, Aging Center, and Arthritis Center
BS (Nutrition and Dietetics), Iowa State University, 1977
BS (Nutrition and Related Sciences), Iowa State University, 1977
MD, The University of Iowa, 1981
Internship and Residence in Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, 1981-1984
Fellowship (Clinical Nutrition), The University of Alabama at Birmingham, 1984-1986
MS (Nutrition), The University of Alabama at Birmingham, 1987
Dr. Morgan's research program has been focused on methotrexate and folic acid metabolism in patients with rheumatoid arthritis. Her work with Dr. Joseph E Baggott and members of the Division of Clinical Immunology and Rheumatology (Drs. Graciela Alarcon, Dr. William Koopman, Dr. S Louis Bridges, and Dr. Laura Hughes) have established the folic acid supplementation during low dose methotrexate therapy for rheumatoid arthritis lowers toxicity without affecting efficacy. Drs Morgan and Baggott have also studied purine metabolism and methotrexate therapy in rat adjuvant arthritis and participate in trials related to methotrexate pharmacogenetics. Dr. Morgan and Dr. Baggott have also investigated the effects of a medical food on osteoarthritis.
Dr. Morgan is currently working on a NIH grant submission with Dr. Jeffrey Curtis related to discontinuation of anti-TNF drugs in individuals in remission of rheumatoid arthritis on methotrexate and an anti-TNF agent.
As the Medical Director of the UAB Osteoporosis Prevention and Treatment Clinic, Dr. Morgan has an interest in bone densitometry and clinical trials related to osteoporosis.
Links:
[1] mailto:slmorgan@uab.edu
[2] http://www.ncbi.nlm.nih.gov/pubmed/3124860
[3] http://www.ncbi.nlm.nih.gov/pubmed/2405864
[4] http://www.ncbi.nlm.nih.gov/pubmed/7978695
[5] http://www.ncbi.nlm.nih.gov/pubmed/9517760
[6] http://www.ncbi.nlm.nih.gov/pubmed/11469449
[7] http://www.ncbi.nlm.nih.gov/pubmed/14558105
[8] http://www.ncbi.nlm.nih.gov/pubmed?term=Morgan%20S%20AND%20Abercrombie
[9] http://www.ncbi.nlm.nih.gov/pubmed/15338486
[10] http://www.ncbi.nlm.nih.gov/pubmed/15476202
[11] http://www.ncbi.nlm.nih.gov/pubmed/15641087
[12] http://www.ncbi.nlm.nih.gov/pubmed/17131945
[13] http://www.ncbi.nlm.nih.gov/pubmed/17408934
[14] http://www.ncbi.nlm.nih.gov/pubmed/18291695
[15] http://www.ncbi.nlm.nih.gov/pubmed/18291694
[16] http://www.ncbi.nlm.nih.gov/pubmed/18809346
[17] http://www.ncbi.nlm.nih.gov/pubmed/19857081
[18] http://www.ncbi.nlm.nih.gov/pubmed/19644884
[19] http://www.ncbi.nlm.nih.gov/pubmed/19863475
[20] http://www.ncbi.nlm.nih.gov/pubmed/20665136
[21] http://www.ncbi.nlm.nih.gov/pubmed?term=Morgan%20S%20AND%20Binkley
[22] http://www.ncbi.nlm.nih.gov/pubmed/21044441
[23] http://www.ncbi.nlm.nih.gov/pubmed/21243354
[24] http://www.ncbi.nlm.nih.gov/pubmed/21324323